Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease

NCT02831205 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

800

Enrollment

OTHER

Sponsor class

Stopped Due to current BVS safety issue

Conditions

Percutaneous Transluminal Coronary Angioplasty

Interventions

DEVICE: everolimus-eluting bioresorbable vascular (Absorb) scaffold
DEVICE: everolimus-eluting cobalt-chromium (Xience) stent

Sponsor

Duk-Woo Park, MD

Collaborators

[object Object]